AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
Sacubitril+Valsartan in Tunisia
6 products registered with DPM — 0 active, 6 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| SACUVAL 100 Comprimé pelliculé / 48.6mg/51.4mg | 9353292 | PHILADELPHIA PHARMA | expired | 17 Jul 2023 |
| SACUVAL 200 Comprimé pelliculé / 97.2mg/102.8mg | 9353293 | PHILADELPHIA PHARMA | expired | 17 Jul 2023 |
| SACUVAL 50 Comprimé pelliculé / 24.3mg/25.7mg | 9353291 | PHILADELPHIA PHARMA | expired | 17 Jul 2023 |
| ENTRESTO Comprimé pelliculé / 100mg | 10283372 | NOVARTIS PHARMA SCHWEIZ AG | expired | 22 Aug 2019 |
| ENTRESTO Comprimé pelliculé / 50mg | 10283371 | NOVARTIS PHARMA SCHWEIZ AG | expired | 22 Aug 2019 |
| ENTRESTO Comprimé pelliculé / 200mg | 10283373 | NOVARTIS PHARMA SCHWEIZ AG | expired | 22 Aug 2019 |
Sacubitril+Valsartan — DPM Registration Details
DPM (Tunisia) has 6 registered products containing Sacubitril+Valsartan, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track Sacubitril+Valsartan registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.